FDA ANDA · ANDA088430

PHENTERMINE HYDROCHLORIDE

Sponsor: UPSHER SMITH LABS

APPLICATION

ANDA088430

TYPE

ANDA

ORIGINAL APPROVAL

1984-03-27

LATEST ACTION

1993-08-24

ROUTE

ORAL

DOSAGE FORM

CAPSULE

MARKETING STATUS

Discontinued

Products

PHENTERMINE HYDROCHLORIDEDiscontinued

PHENTERMINE HYDROCHLORIDE 30MG · CAPSULE · ORAL

1993-08-24Manufacturing (CMC) · Supplement 18AP

1993-08-24Manufacturing (CMC) · Supplement 16AP

1993-08-24Manufacturing (CMC) · Supplement 17AP

1989-10-18Labeling · Supplement 19AP

1988-08-18Manufacturing (CMC) · Supplement 15AP

1986-07-03Manufacturing (CMC) · Supplement 7AP

1986-06-09Manufacturing (CMC) · Supplement 8AP

1985-10-08Manufacturing (CMC) · Supplement 6AP

1985-10-08Manufacturing (CMC) · Supplement 4AP

1985-10-08Manufacturing (CMC) · Supplement 5AP

1984-03-27OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.